Leqembi bisa memberikan pasien Alzheimer lebih banyak waktu, tetapi jalan menuju pengobatan masih panjang
scans or other necessary tests, Petersen said. Some patients may also not have the financial means to cover the costs of the drug or the diagnostic tests, he added. Despite these challenges, experts say the demand for Leqembi is likely to grow as more patients are diagnosed with early-stage Alzheimer’s and as the medical community … Baca Selengkapnya
